The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte‐colony‐stimulating factor and dexamethasone
Abstract
BACKGROUND: The collection of adequate numbers of neutrophils (polymorphonuclear leukocytes, PMNs) from normal donors has long hampered the development of neutrophil transfusion therapy. The stimulation of donors with granulocyte‐colony‐stimulating factor (G‐ CSF) plus dexamethasone is a promising way of improving PMN collections. STUDY DESIGN AND METHODS:Sixteen normal subjects received G‐CSF (600 micrograms subcutaneously) and dexamethasone (8 mg by mouth) 12 hours before leukapheresis. Measurements included PMN morphology, immunophenotype analysis, chemiluminescence, bactericidal activity, in vivo kinetics, and adverse effects. RESULTS:A mean of 77.4 +/− 6.4 × 10(9) PMNs was collected with each leukapheresis; 14 percent were bands. PMNs had increased surface expression of CD11b, CD18, CD14, CD32, and CD64. Bactericidal capacity against Staphylococcus aureus was normal. Inducible respiratory burst was maintained, although the responses to some agonists were diminished. Returned leukapheresis cells labeled with 3H‐diisopropylfluorophosphate had a modestly decreased percentage of recovery and circulated with a prolonged half‐ life. Migration of these cells to skin chambers was approximately equal to that of the subjects' own blood PMNs. Adverse effects included transient bone pain, headache, hunger, and insomnia. CONCLUSIONS:Precollection treatment of leukapheresis donors with G‐CSF plus dexamethasone is an effective way to enhance the collection of PMNs with normal or near‐normal functional properties for PMN transfusion therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral PMN counts are an established measure of functional activity; oral neutrophil counts measure PMN functional status as they reflect the ability of PMNs to transmigrate from the circulation to the mucosal surface [40-43].”
From Oral neutrophils are an independent marker of the systemic inflammatory response after cardiac bypass (2014) · cites this paper as [41]
Citations
Cites
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
Colotta, F., Re, F., Polentarutti, N., Sozzani, S., & Mantovani, A. (1992) · Blood · doi:10.1182/blood.v80.8.2012.2012 · Cited by 1,165
Athens, J. W., Haab, O. P., RAAB, S. O., Mauer, A. M., Ashenbrucker, H., Cartwright, G. E., & Wintrobe, M. M. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104338 · Cited by 639
Dancey, J. T., Deubelbeiss, K. A., Harker, L. A., & Finch, C. A. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108517 · Cited by 573
Cox, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4719 · Cited by 511
Normal Granulocyte Transfusion Therapy
Graw, R. G., Herzig, G. P., Perry, S., & Henderson, E. S. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208242870801 · Cited by 344
Glucocorticoids inhibit apoptosis of human neutrophils
Liles, W. C., Dale, D., & Klebanoff, S. J. (1995) · Blood · doi:10.1182/blood.v86.8.3181.3181 · Cited by 315
Self-citationSinger, J. W., Price, T., Dale, D., Appelbaum, F. R., Clift, R., Lilleby, K., Williams, B., Storb, R. F., Thomas, E. D., & Buckner, C. D. (1993) · Blood · doi:10.1182/blood.v81.7.1883.1883 · Cited by 311
Self-citationPrice, T., Chatta, G., & Dale, D. (1996) · Blood · doi:10.1182/blood.v88.1.335.bloodjournal881335 · Cited by 286
Self-citationNathan, C. F. (1989) · Blood · doi:10.1182/blood.v73.1.301.bloodjournal731301 · Cited by 266
Price, T., Chatta, G., & Dale, D. (1996) · Blood · doi:10.1182/blood.v88.1.335.335 · Cited by 233
Self-citation
Research works printed but not linked: 7
- Leitman SF, 1995, Pair‐controlled study of granulocyte colony stimulating factor (G‐CSF) plus dexamethasone (Dexa) for granulocytapheresis donors (abstract), Transfusion, 35, 53s
- Itoh Y., 1991, In vivo effects of recombinant human granulocyte colony‐stimulating factor on normal PMN function and membrane effector molecule expression, Int J Hematol, 54, 463
- Balazovich KJ, 1991, Recombinant human G‐CSF and GM‐CSF prime human PMN for superoxide production through different signal transduction mechanisms, J Lab Clin Med, 118, 576
- Liles WC, 1994, Differential regulation of human neutrophil surface expression of CD14, CD11b, CD18, and l‐selectin following the administration of G‐CSF in vivo and in vitro, Clin Res, 42, 237a
- 10.1093/infdis/172.4.1061 · DOI
- Bowden R., 1997, Phase I/II study of granulocyte transfusions from G‐CSF‐stimulated unrelated donors for treatment infections in neutropenic blood and marrow transplant (BMT) patients (abstract), Blood, 90, 435a
- Price TH, 1997, Neutrophil collection from community apheresis donors after granulocyte colony‐stimulating factor and dexamethasone stimulation: feasibility and efficacy (abstract), Blood, 90, 137b
Cited by
Sorted by citations
What's your age again? Determination of human neutrophil half-lives revisited
Tak, T., Tesselaar, K., Pillay, J., Borghans, J. A. M., & Koenderman, L. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112571 · Cited by 294
Price, T. H., Boeckh, M., Harrison, R. W., McCullough, J., Ness, P. M., Strauss, R. G., Nichols, W. G., Hamza, T. H., Cushing, M. M., King, K. E., et al. (2015) · Blood · doi:10.1182/blood-2015-05-645986 · Cited by 254
Self-citationEstcourt, L. J., Stanworth, S. J., Doree, C. J., Blanco, P., Hopewell, S., Trivella, M., & Massey, E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005341.pub3 · Cited by 214
Price, T. H., Bowden, R. A., Boeckh, M., Bux, J., Nelson, K., Liles, W. C., & Dale, D. C. (2000) · Blood · doi:10.1182/blood.v95.11.3302 · Cited by 253
Self-citationHübel, K., Dale, D. C., & Liles, W. C. (2002) · The Journal of Infectious Diseases · doi:10.1086/340221 · Cited by 150
Self-citationGazendam, R. P., van de Geer, A., Roos, D., van den Berg, T. K., & Kuijpers, T. W. (2016) · Immunological Reviews · doi:10.1111/imr.12454 · Cited by 151
Peters, C., Minkov, M., Matthes‐Martin, S., Pötschger, U., Witt, V., Mann, G., Höcker, P., Worel, N., Starý, J., Klingebiel, T. E., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01619.x · Cited by 131
Hübel, K., Carter, R. A., Liles, W. C., Dale, D. C., Price, T. H., Bowden, R. A., Rowley, S. D., Chauncey, T. R., Bensinger, W., & Boeckh, M. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00249.x · Cited by 128
Self-citationErythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation
Lizcano, A., Secundino, I., Döhrmann, S., Corriden, R., Rohena, C. C., Diaz, S. L., Ghosh, P., Deng, L., Nizet, V., & Varki, A. P. (2017) · Blood · doi:10.1182/blood-2016-11-751636 · Cited by 111
Current Status of Granulocyte (Neutrophil) Transfusion Therapy for Infectious Diseases
Hübel, K., Dale, D. C., Engert, A., & Liles, W. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/317943 · Cited by 101
Self-citationAdjunctive Immune Therapy for Fungal Infections
Casadevall, A., & Pirofski, L. (2001) · Clinical Infectious Diseases · doi:10.1086/322710 · Cited by 92
Stroncek, D. F., Yau, Y. Y., Oblitas, J., & Leitman, S. F. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41081037.x · Cited by 87
Blood component collection by apheresis
Burgstaler, E. A. (2005) · Journal of Clinical Apheresis · doi:10.1002/jca.20043 · Cited by 81
Anoxia and glucose supplementation preserve neutrophil viability and function
Monceaux, V., Chiche-Lapierre, C., Chaput, C., Witko‐Sarsat, V., Prévost, M., Taylor, C. T., Ungeheuer, M., Sansonetti, P. J., & Marteyn, B. (2016) · Blood · doi:10.1182/blood-2015-11-680918 · Cited by 82
Liles, W. C., Rodger, E., & Dale, D. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40060642.x · Cited by 73
Self-citationFungal infections in nontransplant patients with hematologic malignancies
Segal, B. H., Bow, E. J., & Menichetti, F. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00043-0 · Cited by 67
Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin
Liles, W. C., Thomsen, A. R., O’Mahony, D. S., & Klebanoff, S. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.1.96 · Cited by 64
Self-citationGranulocyte Transfusion: Current Status
Price, T. H. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.09.015 · Cited by 59
Self-citationDrewniak, A., Boelens, J. J., Vrielink, H., Tool, A. T. J., Bruin, M. C. A., van den Heuvel‐Eibrink, M. M., Ball, L. M., van de Wetering, M. D., Roos, D., & Kuijpers, T. W. (2008) · Haematologica · doi:10.3324/haematol.12489 · Cited by 48
Bashir, S., Stanworth, S. J., Massey, E., Goddard, F., & Cardigan, R. A. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.06996.x · Cited by 47
Effects of granulocyte–colony‐stimulating factor on potential normal granulocyte donors
McCullough, J., Clay, M., Herr, G., Smith, J. J., & Stroncek, D. F. (1999) · Transfusion · doi:10.1046/j.1537-2995.1999.39101136.x · Cited by 47
Massey, E., Paulus, U., Doree, C. J., & Stanworth, S. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005341.pub2 · Cited by 42
Functional characteristics of neutrophils collected and stored after administration of G–CSF
Leavey, P. J., Thurman, G. W., & Ambruso, D. R. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40040414.x · Cited by 41
Gaviria, J. M., van Burik, J. H., Dale, D. C., Root, R. K., & Liles, W. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314728 · Cited by 40
Self-citationGazendam, R. P., van de Geer, A., van Hamme, J. L., Tool, A. T. J., van Rees, D. J., Aarts, C. E. M., van den Biggelaar, M., van Alphen, F. P. J., Verkuijlen, P., Meijer, A. B., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136630 · Cited by 34
Fan, Y., Teng, Y., Loison, F., Pang, A., Kasorn, A., Shao, X., Zhang, C., Ren, Q., Yu, H., Zheng, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb1069 · Cited by 36
Hubel, K., Rodger, E., Gaviria, J. M., Price, T. H., Dale, D. C., & Liles, W. C. (2005) · Transfusion · doi:10.1111/j.1537-2995.2005.00636.x · Cited by 34
Self-citationGranulocyte transfusions in neutropenic patients: beneficial effects proven?
Peters, C. (2009) · Vox Sanguinis · doi:10.1111/j.1423-0410.2008.01159.x · Cited by 35
Stroncek, D. F., Matthews, C., Follmann, D. A., & Leitman, S. F. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00091.x · Cited by 34
Immunomodulation of invasive fungal infections
Roilides, E., Lyman, C. A., Panagopoulou, P., & Chanock, S. J. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00070-3 · Cited by 33
Kim, Y., Lee, D., Lee, J.-H., Lee, S., & Lawler, S. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211041 · Cited by 32
Cugno, C., Deola, S., Filippini, P., Stroncek, D. F., & Rutella, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0724-5 · Cited by 32
Alternative Donor Bone Marrow Transplantation for Children With Juvenile Myelomonocytic Leukemia
Bunin, N., Saunders, F., Leahey, A., Doyle, J., Calderwood, S., & Freedman, M. H. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199911000-00007 · Cited by 32
Transfusion Indications for Patients with Cancer
Watkins, T. C., Surowiecka, M., & McCullough, J. (2015) · Cancer Control · doi:10.1177/107327481502200106 · Cited by 32
Efficacy and Side Effects of Granulocyte Collection in Healthy Donors
Brockmann, F., Krämer, M., Bornhäuser, M., Ehninger, G., & Hölig, K. (2013) · Transfusion Medicine and Hemotherapy · doi:10.1159/000354093 · Cited by 29
Immunotherapy for invasive fungal infections: from bench to bedside
Pappas, P. G. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2003.12.002 · Cited by 28
Storage of G–CSF‐mobilized granulocyte concentrates
Lightfoot, T., Leitman, S. F., & Stroncek, D. F. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40091104.x · Cited by 28
Neutrophil (granulocyte) transfusions in the new millennium
Strauss, R. G. (1998) · Transfusion · doi:10.1046/j.1537-2995.1998.38898375508.x · Cited by 28
Granulocyte transfusion therapy: randomization after all?
Drewniak, A., & Kuijpers, T. W. (2009) · Haematologica · doi:10.3324/haematol.2009.013680 · Cited by 27
Granulocyte transfusions in the G-CSF era. Where do we stand?
Robinson, S. P., & Marks, D. I. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704630 · Cited by 27
Drewniak, A., Tool, A. T. J., Geissler, J., van Bruggen, R., van den Berg, T. K., & Kuijpers, T. W. (2010) · Blood · doi:10.1182/blood-2009-11-253245 · Cited by 27
Salzer, A. T., Niemiec, M. J., Hosseinzadeh, A., Stylianou, M., Åström, F., Röhm, M., Ahlm, C., Wåhlin, A., Ermert, D., & Urban, C. F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01968 · Cited by 25
Heuft, H., Goudeva, L., Sel, S., & Blasczyk, R. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00133.x · Cited by 25
Quillen, K., Yau, Y. Y., & Leitman, S. F. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01997.x · Cited by 24
Optimal regulation of tumour-associated neutrophils in cancer progression
Reyes, A. A. D. L., V, & Kim, Y. (2022) · Royal Society Open Science · doi:10.1098/rsos.210705 · Cited by 21
Granulocyte transfusion therapy: it's time for an answer
Price, T. H. (2005) · Transfusion · doi:10.1111/j.1537-2995.2006.00693.x · Cited by 22
Self-citationGranulocyte transfusion: a review
Yeghen, T., & Devereux, S. (2001) · Vox Sanguinis · doi:10.1046/j.1423-0410.2001.00090.x · Cited by 22
Return of granulocyte transfusions
Dale, D. C., & Liles, W. C. (2000) · Current Opinion in Pediatrics · doi:10.1097/00008480-200002000-00004 · Cited by 22
Self-citationFuchsjäger‐Mayrl, G., Malec, M., Polska, E., Jilma, B., Wolzt, M., & Schmetterer, L. F. (2002) · PubMed · Cited by 21
Price, T. H. (2000) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(00)80111-x · Cited by 21
Self-citationJilma, B., Hergovich, N., Homoncik, M., Jilma‐Stohlawetz, P., Kreuzer, C., Eichler, H., Zellner, M., & Pugin, J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02320.x · Cited by 21
Granulocyte transfusion therapy
Price, T. H. (2006) · Journal of Clinical Apheresis · doi:10.1002/jca.20088 · Cited by 20
Self-citationGranulocyte Transfusion Therapy for Treatment of Infections after Cytotoxic Chemotherapy
Hübel, K., & Engert, A. (2003) · Oncology Research and Treatment · doi:10.1159/000069868 · Cited by 18
Joos, K., Herzog, R., Einsele, H., Northoff, H., & Neumeister, B. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00089.x · Cited by 18
Wilcox, M. E., Charbonney, E., d’Empaire, P. P., Duggal, A., Pinto, R., Javid, A., Dos Santos, C., Rubenfeld, G. D., Sutherland, S., Liles, W. C., et al. (2014) · Journal of Inflammation · doi:10.1186/s12950-014-0032-5 · Cited by 17
Self-citationConcise Review: Next-Generation Cell Therapies to Prevent Infections in Neutropenic Patients
Brunck, M. E. G., & Nielsen, L. K. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0145 · Cited by 17
Rapid down modulation of P‐selectin glycoprotein ligand‐1 (PSGL‐1, CD162) by G–CSF in humans
Jilma, B., Hergovich, N., Homoncik, M., Marsik, C. L., Kreuzer, C., & Jilma‐Stohlawetz, P. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00045.x · Cited by 17
Granulocyte transfusion in the G-CSF era
Price, T. H. (2002) · International Journal of Hematology · doi:10.1007/bf03165092 · Cited by 17
Self-citationBlasczyk, R., Heuft, H. G., & Goudeva, L. (2004) · Annals of Hematology · doi:10.1007/s00277-003-0816-9 · Cited by 16
Dullinger, K., Pamler, I., Brosig, A. M., Mohrez, M., Hähnel, V., Offner, R., Dormann, F., Becke, C., Holler, E., & Ahrens, N. (2016) · Transfusion · doi:10.1111/trf.13898 · Cited by 15
Granulocyte transfusion therapy: a new era?
Dale, D. C., & Price, T. H. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831d7953 · Cited by 15
Self-citationWeingarten, C., Pliez, S., Tschiedel, E., Grasemann, C., Kreissig, C., & Schündeln, M. M. (2016) · European Journal of Pediatrics · doi:10.1007/s00431-016-2774-y · Cited by 13
Heuft, H., Goudeva, L., Pulver, N., Grigull, L., Schwella, N., & Blasczyk, R. (2005) · Transfusion · doi:10.1111/j.0041-1132.2005.04240.x · Cited by 13
Rational use of blood products
Solheim, B. G., & Wesenberg, F. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00324-0 · Cited by 12
Is it time for a new look at granulocyte transfusions?
van Burik, J. H., & Weisdorf, D. J. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00296.x · Cited by 11
Hiemstra, I. H., van Hamme, J. L., Janssen, M. H., van den Berg, T. K., & Kuijpers, T. W. (2016) · Transfusion · doi:10.1111/trf.13941 · Cited by 10
Heuft, H., Goudeva, L., Schwella, N., & Blasczyk, R. (2004) · Transfusion · doi:10.1111/j.1537-2995.2004.03283.x · Cited by 10
Abbiati, R. A., Pourdehnad, M., Carrancio, S., Pierce, D. W., Kasibhatla, S., McConnell, M. T., Trotter, M. W. B., Loos, R., Santini, C. C., & Ratushny, A. V. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00623-8 · Cited by 8
Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients
Matikas, A., Georgoulias, V., & Kotsakis, A. P. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1184646 · Cited by 7
Schmitt, A., Reinhardt, P., Schmitt, M., Nowak-Harnau, S., Maccari, B., Schulz, A., Kubanek, B., & Wiesneth, M. (2002) · Transfusion Medicine and Hemotherapy · doi:10.1159/000057091 · Cited by 6
Domen, J., Christensen, J. L., Gille, D., Smith‐Berdan, S., Fong, T. C., Brown, J. W., & Sedello, A. (2016) · Cell Transplantation · doi:10.3727/096368915x687688 · Cited by 5
Gordon, B. C., Revenis, A. M., Bonifacino, A. C., Sander, W. R., Metzger, M. E., Krouse, A. E., Usherson, T. N., & Donahue, R. E. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.03.011 · Cited by 5
Alloimmunization and granulocyte transfusion: a new study confirms old lessons
McCullough, J. (2011) · Transfusion · doi:10.1111/j.1537-2995.2011.03195.x · Cited by 5
Ginzburg, Y. Z., Kessler, D. A., Narici, M., Caltabiano, M., Rebosa, M., Strauss, D., & Shaz, B. H. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03938.x · Cited by 4
Sulis, M. L., van de Ven, C., Henderson, T. R., Anderson, L., & Cairo, M. S. (2002) · Blood · doi:10.1182/blood.v99.1.384 · Cited by 4
Rimajova, V., Sopko, L., Martinka, J., Kubalova, S., & Mistrik, M. (2012) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2012_041 · Cited by 4
Einsele, H., Northoff, H., & Neumeister, B. (2004) · Vox Sanguinis · doi:10.1111/j.1741-6892.2004.00483.x · Cited by 4
Granulocyte Colony Stimulating Factor (G‐CSF)
Welte, K. (2000) · doi:10.1002/9783527613021.ch05 · Cited by 4
Clinical Uses of Blood Components
McCullough, J. (2011) · Transfusion Medicine · doi:10.1002/9781444398748.ch11 · Cited by 4
Granulocyte transfusion therapy
Tanhehco, Y. C. (2021) · Annals of Blood · doi:10.21037/aob-21-46 · Cited by 3
Shrivastava, S. P., Elhence, A., Jinwala, P., Bansal, S., Chitalkar, P. G., Bhatnagar, S., Patidar, R., Asati, V., & Reddy, P. K. (2022) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0042-1757730 · Cited by 3
Renewed granulocyte support practice and its alternatives
Balint, B. (2004) · Vojnosanitetski pregled · doi:10.2298/vsp0405537b · Cited by 3
Aung, F. M., Lichtiger, B., Bassett, R. L., Hosing, C. M., & Freireich, E. J. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.883619 · Cited by 3
Winters, J. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00037-3 · Cited by 3
Immunomodulatory therapy in yeast infections
Garbino, J., Katragkou, A., & Roilides, E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.1.129 · Cited by 3
Li, L., Yang, Y., Guo, Z., Gao, X., Liu, L., Huang, J., & Sun, B. (2024) · Cell Transplantation · doi:10.1177/09636897241228031 · Cited by 2
Lee, D., Oh, S., Lawler, S. E., & Kim, Y. (2025) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2025028 · Cited by 2
Granulocyte transfusions: where is the controversy?
Gea‐Banacloche, J. (2011) · Cytotherapy · doi:10.3109/14653249.2011.555096 · Cited by 2
Kessler, K., Goudeva, L., & Heuft, H. (2011) · Journal of Clinical Apheresis · doi:10.1002/jca.20316 · Cited by 2
Transfused neutrophils home to a joint with fungal infection
Ward, D. C., Beaulieu, G. P., Leitman, S. F., & Flegel, W. A. (2016) · Transfusion · doi:10.1111/trf.13743 · Cited by 2
Assessing energy efficiency in maltese dwellings
Yousif, C. (2015) · doi:10.35376/10324/13864 · Cited by 2
The Transfusion of Platelets, Leucocytes, Haematopoietic Cells and Plasma Components
Klein, H. G., & FMedSci, D. J. A. P. F. (2005) · doi:10.1002/9780470986868.ch14 · Cited by 2
Immunotherapy for Fungal Infections
Casadevall, A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-171-8_18 · Cited by 1
John, L., Arif Vaheedu, A. A., Ramanadhan, P., Murugesan, M., & Shenoy, V. (2025) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2025.104284 · Cited by 1
Platelet and Granulocyte Transfusion
Dutcher, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_54 · Cited by 1
Immunotherapy for Difficult-to-Treat Invasive Fungal Diseases
Segal, B. H., Safdar, A., & Stevens, D. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_29 · Cited by 1
Factors influencing white blood cell mobilisation in healthy granulocyte donors
Gonta, R., Schenkel, J. M., Klein, K. L., Martinez, F., & Medina, M. C. (2024) · Transfusion Medicine · doi:10.1111/tme.13115 · Cited by 1
Transfusion in Transplantation
Davulcu, E. A., Şahin, F., & Saydam, G. (2017) · InTech eBooks · doi:10.5772/intechopen.69260 · Cited by 1
Colony-stimulating factors: altering the practice of oncology
Welte, K., & Platzer, E. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8346-7_4 · Cited by 1
Exchange Transfusion and Haemapheresis
(2005) · Wiley eBooks · doi:10.1002/9780470986868.ch17 · Cited by 1
Metadata
- Authors
- Dale, D. C., Liles, W. C., Llewellyn, C., Rodger, E., & Price, T. H.
- Affiliations
- University of Washington (US)
- Corresponding author
- Dale, D.C.
- ORCID
- Dale, D.C.
- Venue
- Transfusion
- Publisher
- Wiley
- Published
- 1998-08
- Volume
- 38
- Issue
- 8
- Pages
- 713-721
- ISSN
- 0041-1132 (ISSN-L)
- 1537-2995
- OpenAlex
- W2093230583
- Cited by
- 124
- References
- 41
- Citations by year
- 2025: 2 · 2024: 2 · 2022: 3 · 2021: 4 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 11 · 2015: 8 · 2014: 4 · 2013: 5 · 2012: 5
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transfusion (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl053515-03)
- National Heart, Lung, and Blood Institute (HL53515-02)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- neutrophil transfusion, granulocyte colony-stimulating factor, dexamethasone, leukapheresis, donor mobilization, neutrophil kinetics, neutrophil migration, bactericidal activity, respiratory burst, CD11b, CD64, Staphylococcus aureus, adverse effects
- MeSH terms
- Adult, Cell Movement, Dexamethasone, Female, Humans, Leukapheresis, Leukocyte Count, Luminescent Measurements, Male, Middle Aged, Neutrophils, Staphylococcus aureus, Antigens, CD, Immunophenotyping, Granulocyte Colony-Stimulating Factor, Respiratory Burst, Leukocyte Transfusion, L-Selectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review